|
Closure of the tipranavir trials SPRING and TICINO
|
06 August 2008 |
|
Boehringer Ingelheim FENS Award for exceptional research in neuroscience
|
16 July 2008 |
|
First positive health technology assessments for novel oral anticoagulant Pradaxa®
|
10 June 2008 |
|
Boehringer Ingelheim announces commitment to progressing science with the Bouquet Studies
|
12 May 2008 |
|
European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®)
|
06 May 2008 |
|
Novel oral anticoagulant Pradaxa® (dabigatran etexilate) approved by the European Commission
|
28 March 2008 |
|
FDA grants fast track designation for Boehringer Ingelheim's BIBW 2992
|
18 February 2008 |
|
Award recognises and rewards journalism that extends public awareness and understanding of COPD
|
15 November 2007 |
|
Boehringer Ingelheim distinguished as number one Top Employer 2007 by Science Magazine
|
12 October 2007 |
|
Aptivus® (tipranavir) capsules granted full approval by the U.S. FDA
|
09 October 2007 |
|
Boehringer Ingelheim comments the nevirapine production for Rwanda by Apotex
|
03 October 2007 |
|
ERS COPD Research Awards 2007 Sponsored by Boehringer Ingelheim
|
17 September 2007 |
|
Boehringer Ingelheim announce major global strategic alliance in novel nanobody® therapeutics
|
07 September 2007 |
|
Key business with prescription medicines continues to boost growth at Boehringer Ingelheim
|
26 July 2007 |
|
New Spiriva® Respimat® inhaler completes European approval process for COPD
|
25 July 2007 |
|
Boehringer Ingelheim announces first international head-to-head trial of Aptivus®
|
24 July 2007 |